Doxorubicin enhances CD4+ T-cell immune responses by inducing expression of CD40 ligand and 4-1BB
β Scribed by Jae Yeo Park; Min Ja Jang; Yoon Hee Chung; Kyung Yong Kim; Sung Su Kim; Won Bok Lee; Seungkwon You; Youn Seok Choi; Dae Young Hur; Daejin Kim
- Book ID
- 116576614
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 802 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1567-5769
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract 4β1BBL^β/β^ mice have a defect in recall CD8^+^ T cell responses to viruses, whereas CD4^+^ T cell responses to virus are unimpaired in these mice. In contrast, both CD4^+^ and CD8^+^ T cells respond to 4β1BB ligand (4β1BBL) __in vitro__. To clarify the role of 4β1BB/4β1BBL in CD4^+^ ve
## Abstract The T cell surface protein CD28 provides a critical costimulatory signal for T cell activation. With age, humans accumulate increasing numbers of CD28^β^ T cells, and this loss of CD28 expression is exacerbated certain disease states, such as HIV infection, autoimmune conditions or canc